PMID: 9550813Apr 29, 1998Paper

Immunology in clinical practice. VI. Current immunosuppressive drugs

Nederlands tijdschrift voor geneeskunde
R J ten Berge, P T Schellekens

Abstract

Immunosuppressive drugs are agents capable of modulating at least one type of immune response in vivo at doses with tolerable side-effects. Classical immunosuppressive drugs include corticosteroids, azathioprine, cyclophosphamide, methotrexate and cyclosporine. In the past two years tacrolimus and mycophenolate mofetil were registered as immunosuppressive drugs. Tacrolimus interferes with the calcium-dependent signal transduction of T-lymphocytes. Mycophenolate mofetil is an inhibitor of purine synthesis by inhibition of the enzyme inosine monophosphate dehydrogenase. Both tacrolimus and mycophenolate mofetil have proven efficacy in both prevention and treatment of acute allograft rejection. The new drugs are stronger than the classical ones but do not cause more adverse reactions. The value in clinical medicine of some new, promising immunosuppressive drugs, i.e. sirolimus (rapamycin), mizoribine, brequinar and leflunomide remains to be proven.

Related Concepts

Related Feeds

Calcium & Bioenergetics

Bioenergetic processes, including cellular respiration and photosynthesis, concern the transformation of energy by cells. Here is the latest research on the role of calcium in bioenergetics.

Related Papers

Pediatric Nephrology : Journal of the International Pediatric Nephrology Association
M Suthanthiran, T B Strom
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
M SuthanthiranT B Strom
© 2022 Meta ULC. All rights reserved